Michael Hayden Rosenthal, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pancreatic Neoplasms | 19 | 2023 | 5249 | 1.930 |
Why?
|
Tomography, X-Ray Computed | 26 | 2022 | 20086 | 1.010 |
Why?
|
Carcinoma, Pancreatic Ductal | 7 | 2023 | 1631 | 0.950 |
Why?
|
Adenocarcinoma | 8 | 2022 | 6347 | 0.820 |
Why?
|
Rectal Neoplasms | 3 | 2019 | 1195 | 0.740 |
Why?
|
Body Composition | 6 | 2023 | 2400 | 0.670 |
Why?
|
Radiography, Abdominal | 1 | 2020 | 537 | 0.600 |
Why?
|
Pancreas | 3 | 2022 | 1684 | 0.550 |
Why?
|
Cholangiopancreatography, Magnetic Resonance | 1 | 2015 | 101 | 0.510 |
Why?
|
Anus Neoplasms | 2 | 2019 | 332 | 0.440 |
Why?
|
Outpatients | 1 | 2020 | 1483 | 0.440 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 1 | 2015 | 504 | 0.430 |
Why?
|
Early Detection of Cancer | 2 | 2022 | 3070 | 0.390 |
Why?
|
Neoplasm Staging | 8 | 2022 | 11001 | 0.380 |
Why?
|
Colorectal Neoplasms | 6 | 2019 | 6754 | 0.370 |
Why?
|
Stomach Neoplasms | 2 | 2017 | 1327 | 0.360 |
Why?
|
ras Proteins | 1 | 2014 | 1060 | 0.340 |
Why?
|
Cellulitis | 1 | 2011 | 206 | 0.340 |
Why?
|
Diagnostic Imaging | 7 | 2021 | 3507 | 0.330 |
Why?
|
Fractures, Spontaneous | 1 | 2010 | 230 | 0.320 |
Why?
|
Adenocarcinoma, Bronchiolo-Alveolar | 1 | 2008 | 91 | 0.310 |
Why?
|
Abscess | 1 | 2011 | 607 | 0.290 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 3 | 2018 | 484 | 0.290 |
Why?
|
Adenocarcinoma, Follicular | 1 | 2010 | 324 | 0.280 |
Why?
|
Femoral Fractures | 1 | 2010 | 376 | 0.280 |
Why?
|
Neck | 1 | 2011 | 693 | 0.280 |
Why?
|
Image Processing, Computer-Assisted | 3 | 2020 | 8925 | 0.280 |
Why?
|
Sarcopenia | 2 | 2021 | 368 | 0.280 |
Why?
|
Diagnosis, Differential | 9 | 2019 | 12958 | 0.240 |
Why?
|
Testicular Neoplasms | 3 | 2015 | 761 | 0.240 |
Why?
|
Femur | 1 | 2010 | 1297 | 0.240 |
Why?
|
Proto-Oncogene Proteins | 2 | 2023 | 4553 | 0.230 |
Why?
|
Positron-Emission Tomography | 4 | 2015 | 6259 | 0.230 |
Why?
|
Molecular Targeted Therapy | 4 | 2015 | 2723 | 0.230 |
Why?
|
Bile Ducts, Intrahepatic | 2 | 2014 | 295 | 0.220 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2015 | 4029 | 0.220 |
Why?
|
Bacterial Infections | 1 | 2011 | 1389 | 0.210 |
Why?
|
Terminology as Topic | 2 | 2019 | 1548 | 0.210 |
Why?
|
Bone Neoplasms | 2 | 2014 | 2522 | 0.210 |
Why?
|
Humans | 65 | 2024 | 742088 | 0.200 |
Why?
|
Artificial Intelligence | 3 | 2023 | 2187 | 0.190 |
Why?
|
Weight Loss | 2 | 2024 | 2604 | 0.190 |
Why?
|
Histiocytes | 1 | 2021 | 103 | 0.190 |
Why?
|
User-Computer Interface | 3 | 2008 | 1426 | 0.190 |
Why?
|
Ultrasonography, Mammary | 1 | 2002 | 250 | 0.180 |
Why?
|
Biopsy, Needle | 2 | 2003 | 1640 | 0.180 |
Why?
|
Computer Graphics | 1 | 2002 | 360 | 0.180 |
Why?
|
Radiology | 4 | 2022 | 2090 | 0.180 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2022 | 647 | 0.170 |
Why?
|
Bile Duct Neoplasms | 2 | 2014 | 567 | 0.170 |
Why?
|
Cholangiocarcinoma | 2 | 2014 | 516 | 0.170 |
Why?
|
Adipose Tissue | 3 | 2023 | 3278 | 0.170 |
Why?
|
Muscle, Skeletal | 4 | 2023 | 4933 | 0.160 |
Why?
|
Peritoneal Neoplasms | 2 | 2014 | 663 | 0.160 |
Why?
|
Magnetic Resonance Imaging | 7 | 2019 | 35342 | 0.160 |
Why?
|
Tumor Escape | 1 | 2021 | 349 | 0.160 |
Why?
|
Exocrine Pancreatic Insufficiency | 1 | 2018 | 80 | 0.150 |
Why?
|
Hepatic Artery | 1 | 2018 | 242 | 0.150 |
Why?
|
Fluorouracil | 2 | 2019 | 1615 | 0.150 |
Why?
|
Imaging, Three-Dimensional | 2 | 2018 | 4029 | 0.150 |
Why?
|
Thyroid Neoplasms | 1 | 2010 | 2274 | 0.150 |
Why?
|
Anal Canal | 2 | 2019 | 376 | 0.140 |
Why?
|
Soft Tissue Neoplasms | 3 | 2015 | 1361 | 0.140 |
Why?
|
Middle Aged | 28 | 2024 | 213127 | 0.140 |
Why?
|
DNA Mismatch Repair | 1 | 2019 | 424 | 0.140 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2019 | 640 | 0.130 |
Why?
|
Calculi | 1 | 2015 | 46 | 0.130 |
Why?
|
Abdomen | 1 | 2021 | 1107 | 0.130 |
Why?
|
Sarcoma | 3 | 2016 | 1895 | 0.130 |
Why?
|
Sex Distribution | 1 | 2020 | 2295 | 0.130 |
Why?
|
Radiography | 3 | 2021 | 7010 | 0.130 |
Why?
|
Hormone Antagonists | 1 | 2015 | 107 | 0.130 |
Why?
|
Lung Neoplasms | 4 | 2023 | 13019 | 0.130 |
Why?
|
Duodenal Neoplasms | 1 | 2015 | 106 | 0.130 |
Why?
|
Pancreatectomy | 1 | 2019 | 802 | 0.130 |
Why?
|
Liposarcoma, Myxoid | 1 | 2015 | 64 | 0.130 |
Why?
|
Neoplasms | 6 | 2024 | 21596 | 0.130 |
Why?
|
Rectum | 2 | 2019 | 903 | 0.120 |
Why?
|
Age Distribution | 1 | 2020 | 2900 | 0.120 |
Why?
|
Esophageal Neoplasms | 2 | 2015 | 1581 | 0.120 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 2018 | 546 | 0.120 |
Why?
|
Lymphatic Metastasis | 3 | 2019 | 2906 | 0.120 |
Why?
|
Myxoma | 1 | 2015 | 130 | 0.120 |
Why?
|
Lymphatic System | 1 | 2015 | 253 | 0.120 |
Why?
|
Gastrointestinal Diseases | 1 | 2022 | 1167 | 0.120 |
Why?
|
Male | 32 | 2024 | 349538 | 0.120 |
Why?
|
Genomics | 2 | 2021 | 5692 | 0.120 |
Why?
|
Bone Marrow Neoplasms | 1 | 2014 | 104 | 0.110 |
Why?
|
Pancreatic Ducts | 1 | 2015 | 328 | 0.110 |
Why?
|
Penile Neoplasms | 1 | 2015 | 159 | 0.110 |
Why?
|
Reference Values | 1 | 2020 | 4982 | 0.110 |
Why?
|
Diabetes Complications | 1 | 2020 | 1359 | 0.110 |
Why?
|
Mutation | 3 | 2023 | 29717 | 0.110 |
Why?
|
Tumor Virus Infections | 1 | 2015 | 451 | 0.110 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 2 | 2023 | 1683 | 0.110 |
Why?
|
Seminoma | 1 | 2013 | 136 | 0.110 |
Why?
|
Neuroendocrine Tumors | 2 | 2015 | 594 | 0.110 |
Why?
|
Hepatitis B Virus, Woodchuck | 1 | 2011 | 6 | 0.100 |
Why?
|
Osteoporosis | 1 | 2021 | 1581 | 0.100 |
Why?
|
Gastrointestinal Stromal Tumors | 2 | 2015 | 642 | 0.100 |
Why?
|
Lymphatic Diseases | 1 | 2013 | 324 | 0.100 |
Why?
|
Survival Analysis | 4 | 2021 | 10248 | 0.100 |
Why?
|
Observer Variation | 2 | 2014 | 2593 | 0.100 |
Why?
|
Retrospective Studies | 11 | 2021 | 77098 | 0.100 |
Why?
|
Cachexia | 2 | 2023 | 203 | 0.100 |
Why?
|
Female | 26 | 2024 | 379592 | 0.100 |
Why?
|
Edema | 1 | 2015 | 790 | 0.100 |
Why?
|
Teratoma | 1 | 2014 | 387 | 0.100 |
Why?
|
Hormones | 1 | 2015 | 884 | 0.100 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2021 | 1377 | 0.100 |
Why?
|
Liver Neoplasms, Experimental | 1 | 2011 | 191 | 0.090 |
Why?
|
Elasticity Imaging Techniques | 1 | 2015 | 388 | 0.090 |
Why?
|
Biopsy, Fine-Needle | 1 | 2015 | 1093 | 0.090 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2015 | 1769 | 0.090 |
Why?
|
Combined Modality Therapy | 3 | 2019 | 8621 | 0.090 |
Why?
|
Ultrasonography | 4 | 2016 | 5978 | 0.090 |
Why?
|
Neoplasm Metastasis | 3 | 2015 | 4839 | 0.090 |
Why?
|
Lymphoma, Follicular | 1 | 2013 | 435 | 0.090 |
Why?
|
Aged | 18 | 2024 | 162944 | 0.090 |
Why?
|
Fatal Outcome | 2 | 2014 | 1849 | 0.090 |
Why?
|
Papillomaviridae | 1 | 2015 | 1118 | 0.090 |
Why?
|
Carcinoma, Basal Cell | 1 | 2015 | 545 | 0.090 |
Why?
|
Reproducibility of Results | 4 | 2020 | 19862 | 0.080 |
Why?
|
Drug Monitoring | 1 | 2015 | 956 | 0.080 |
Why?
|
Neoadjuvant Therapy | 1 | 2019 | 2721 | 0.080 |
Why?
|
Lymphoma | 2 | 2014 | 1873 | 0.080 |
Why?
|
Aged, 80 and over | 9 | 2020 | 57683 | 0.080 |
Why?
|
Thromboembolism | 1 | 2014 | 983 | 0.080 |
Why?
|
Angiogenesis Inhibitors | 2 | 2015 | 2038 | 0.080 |
Why?
|
Surgery, Oral | 1 | 2011 | 146 | 0.080 |
Why?
|
Computer Terminals | 1 | 2008 | 44 | 0.080 |
Why?
|
Antineoplastic Agents | 3 | 2015 | 13655 | 0.080 |
Why?
|
Evidence-Based Medicine | 1 | 2019 | 3611 | 0.080 |
Why?
|
Neoplasm Invasiveness | 1 | 2015 | 3612 | 0.080 |
Why?
|
Vascular Endothelial Growth Factor A | 2 | 2015 | 3502 | 0.070 |
Why?
|
Prognosis | 5 | 2021 | 29010 | 0.070 |
Why?
|
Radiotherapy Planning, Computer-Assisted | 1 | 2015 | 1622 | 0.070 |
Why?
|
Contrast Media | 4 | 2015 | 5295 | 0.070 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2015 | 1509 | 0.070 |
Why?
|
Marketing of Health Services | 1 | 2007 | 153 | 0.070 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 2 | 2023 | 5171 | 0.070 |
Why?
|
Catheter Ablation | 2 | 2011 | 2746 | 0.070 |
Why?
|
Radionuclide Imaging | 1 | 2010 | 2027 | 0.070 |
Why?
|
Hepatitis B | 1 | 2011 | 695 | 0.070 |
Why?
|
Gene Expression Profiling | 2 | 2019 | 9410 | 0.070 |
Why?
|
Thyroidectomy | 1 | 2010 | 877 | 0.060 |
Why?
|
Follow-Up Studies | 5 | 2024 | 39004 | 0.060 |
Why?
|
Reminder Systems | 1 | 2007 | 370 | 0.060 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2019 | 5163 | 0.060 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2014 | 2940 | 0.060 |
Why?
|
Papillomavirus Infections | 1 | 2015 | 1585 | 0.060 |
Why?
|
Coronary Artery Disease | 1 | 2023 | 6454 | 0.060 |
Why?
|
Patient Selection | 1 | 2015 | 4214 | 0.060 |
Why?
|
T-Lymphocytes | 1 | 2021 | 10163 | 0.060 |
Why?
|
Carcinoma, Hepatocellular | 2 | 2015 | 2211 | 0.060 |
Why?
|
Cross-Sectional Studies | 2 | 2021 | 24913 | 0.060 |
Why?
|
Adult | 13 | 2020 | 213712 | 0.050 |
Why?
|
Equipment Design | 3 | 2011 | 3582 | 0.050 |
Why?
|
Carcinoma | 1 | 2014 | 2374 | 0.050 |
Why?
|
Genetic Variation | 1 | 2018 | 6540 | 0.050 |
Why?
|
Hemorrhage | 1 | 2014 | 3461 | 0.050 |
Why?
|
Body Weight | 2 | 2024 | 4664 | 0.050 |
Why?
|
Inflammation | 1 | 2022 | 10578 | 0.050 |
Why?
|
Colonic Neoplasms | 1 | 2014 | 2542 | 0.050 |
Why?
|
Head | 1 | 2008 | 878 | 0.050 |
Why?
|
Sensitivity and Specificity | 2 | 2011 | 14720 | 0.050 |
Why?
|
Predictive Value of Tests | 2 | 2023 | 15056 | 0.050 |
Why?
|
Privacy | 1 | 2023 | 237 | 0.050 |
Why?
|
Intention | 1 | 2024 | 338 | 0.050 |
Why?
|
Cohort Studies | 2 | 2020 | 40450 | 0.050 |
Why?
|
Palliative Care | 1 | 2015 | 3478 | 0.050 |
Why?
|
Proportional Hazards Models | 1 | 2015 | 12344 | 0.050 |
Why?
|
Muscular Atrophy | 1 | 2023 | 350 | 0.050 |
Why?
|
Genotype | 1 | 2014 | 12946 | 0.040 |
Why?
|
Heart Failure | 1 | 2023 | 10856 | 0.040 |
Why?
|
Protein Kinase Inhibitors | 1 | 2015 | 5522 | 0.040 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2016 | 11472 | 0.040 |
Why?
|
Obesity, Abdominal | 1 | 2021 | 361 | 0.040 |
Why?
|
Models, Anatomic | 1 | 2002 | 690 | 0.040 |
Why?
|
Breast Neoplasms | 2 | 2003 | 20774 | 0.040 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2023 | 9185 | 0.040 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2015 | 5425 | 0.040 |
Why?
|
Antibodies, Monoclonal | 1 | 2014 | 9274 | 0.040 |
Why?
|
Patient Education as Topic | 1 | 2007 | 2275 | 0.040 |
Why?
|
Risk Assessment | 1 | 2018 | 23320 | 0.040 |
Why?
|
Liver Neoplasms | 2 | 2015 | 4249 | 0.040 |
Why?
|
Frail Elderly | 1 | 2021 | 691 | 0.040 |
Why?
|
Risk Factors | 3 | 2023 | 72145 | 0.040 |
Why?
|
Skin Neoplasms | 1 | 2015 | 5662 | 0.030 |
Why?
|
Organoplatinum Compounds | 1 | 2016 | 408 | 0.030 |
Why?
|
Fibromatosis, Aggressive | 1 | 2016 | 118 | 0.030 |
Why?
|
Leucovorin | 1 | 2016 | 624 | 0.030 |
Why?
|
Antigens, Neoplasm | 1 | 2023 | 1983 | 0.030 |
Why?
|
Anemia, Myelophthisic | 1 | 2014 | 6 | 0.030 |
Why?
|
Interdisciplinary Communication | 1 | 2021 | 950 | 0.030 |
Why?
|
Pancreaticoduodenectomy | 1 | 2018 | 503 | 0.030 |
Why?
|
Preoperative Period | 1 | 2016 | 546 | 0.030 |
Why?
|
Review Literature as Topic | 1 | 2016 | 333 | 0.030 |
Why?
|
Tumor Lysis Syndrome | 1 | 2014 | 42 | 0.030 |
Why?
|
Cholangiography | 1 | 2014 | 189 | 0.030 |
Why?
|
Phantoms, Imaging | 1 | 2002 | 2466 | 0.030 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2023 | 2455 | 0.030 |
Why?
|
Spermatocytes | 1 | 2013 | 42 | 0.030 |
Why?
|
Mesenchymoma | 1 | 2014 | 47 | 0.030 |
Why?
|
Learning | 1 | 2023 | 1705 | 0.030 |
Why?
|
Penis | 1 | 2015 | 216 | 0.030 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2023 | 2028 | 0.030 |
Why?
|
Disseminated Intravascular Coagulation | 1 | 2014 | 188 | 0.030 |
Why?
|
Peritoneum | 1 | 2014 | 226 | 0.030 |
Why?
|
Ascites | 1 | 2015 | 344 | 0.030 |
Why?
|
Pericardial Effusion | 1 | 2015 | 246 | 0.030 |
Why?
|
Antihypertensive Agents | 1 | 2023 | 2043 | 0.030 |
Why?
|
Bile Ducts | 1 | 2014 | 284 | 0.030 |
Why?
|
Rhabdomyosarcoma | 1 | 2016 | 382 | 0.030 |
Why?
|
Pleural Effusion | 1 | 2015 | 338 | 0.030 |
Why?
|
Marmota | 1 | 2011 | 12 | 0.030 |
Why?
|
Duodenum | 1 | 2015 | 483 | 0.030 |
Why?
|
Mass Screening | 1 | 2007 | 5238 | 0.030 |
Why?
|
Drug Therapy | 1 | 2014 | 497 | 0.030 |
Why?
|
Orchiectomy | 1 | 2013 | 466 | 0.020 |
Why?
|
Image Interpretation, Computer-Assisted | 2 | 2015 | 3328 | 0.020 |
Why?
|
Endosonography | 1 | 2015 | 610 | 0.020 |
Why?
|
MAP Kinase Signaling System | 1 | 2018 | 1525 | 0.020 |
Why?
|
Ventricular Function, Left | 1 | 2023 | 3656 | 0.020 |
Why?
|
Biopsy | 2 | 2014 | 6756 | 0.020 |
Why?
|
Hypoglycemic Agents | 1 | 2023 | 2866 | 0.020 |
Why?
|
DNA Copy Number Variations | 1 | 2019 | 1940 | 0.020 |
Why?
|
Stroke Volume | 1 | 2023 | 4983 | 0.020 |
Why?
|
Neoplasm Proteins | 1 | 2023 | 3691 | 0.020 |
Why?
|
Consensus | 1 | 2019 | 2935 | 0.020 |
Why?
|
Health Personnel | 1 | 2024 | 3210 | 0.020 |
Why?
|
Germ-Line Mutation | 1 | 2018 | 1786 | 0.020 |
Why?
|
Radiographic Image Enhancement | 1 | 2015 | 885 | 0.020 |
Why?
|
Sequence Analysis, RNA | 1 | 2018 | 2011 | 0.020 |
Why?
|
Radiation Dosage | 1 | 2018 | 1927 | 0.020 |
Why?
|
Adolescent | 3 | 2015 | 85649 | 0.020 |
Why?
|
Proteomics | 1 | 2023 | 3618 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2018 | 1707 | 0.020 |
Why?
|
Treatment Outcome | 4 | 2019 | 62966 | 0.020 |
Why?
|
Lung | 1 | 2008 | 9826 | 0.020 |
Why?
|
Tumor Burden | 1 | 2015 | 1905 | 0.020 |
Why?
|
Computer Simulation | 1 | 2003 | 6191 | 0.020 |
Why?
|
Statistics as Topic | 1 | 2015 | 2372 | 0.020 |
Why?
|
Radiotherapy | 1 | 2016 | 1525 | 0.020 |
Why?
|
DNA Repair | 1 | 2018 | 2042 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2019 | 2183 | 0.020 |
Why?
|
Young Adult | 4 | 2015 | 56350 | 0.020 |
Why?
|
Population Surveillance | 1 | 2018 | 2616 | 0.020 |
Why?
|
Societies, Medical | 1 | 2019 | 3740 | 0.020 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2015 | 1659 | 0.020 |
Why?
|
Necrosis | 1 | 2011 | 1643 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2019 | 3585 | 0.020 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2015 | 2107 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2019 | 11363 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2015 | 5062 | 0.020 |
Why?
|
DNA Methylation | 1 | 2019 | 4282 | 0.020 |
Why?
|
Survival Rate | 1 | 2019 | 12773 | 0.020 |
Why?
|
Databases, Factual | 1 | 2019 | 7716 | 0.020 |
Why?
|
Radiopharmaceuticals | 1 | 2014 | 2658 | 0.010 |
Why?
|
Liver | 1 | 2019 | 7470 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2019 | 13921 | 0.010 |
Why?
|
Body Mass Index | 1 | 2020 | 12695 | 0.010 |
Why?
|
Child | 1 | 2011 | 77478 | 0.010 |
Why?
|
Algorithms | 1 | 2023 | 13853 | 0.010 |
Why?
|
North Carolina | 1 | 2003 | 311 | 0.010 |
Why?
|
Incidence | 1 | 2020 | 20928 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2018 | 8425 | 0.010 |
Why?
|
Quality of Life | 1 | 2023 | 12730 | 0.010 |
Why?
|
Disease Progression | 1 | 2018 | 13256 | 0.010 |
Why?
|
Hospitalization | 1 | 2021 | 10232 | 0.010 |
Why?
|
Obesity | 1 | 2023 | 12705 | 0.010 |
Why?
|
Glioma | 1 | 2015 | 3388 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2016 | 7276 | 0.010 |
Why?
|
Prospective Studies | 1 | 2024 | 53187 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2018 | 18006 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2014 | 10472 | 0.010 |
Why?
|
United States | 2 | 2019 | 69693 | 0.010 |
Why?
|
Health Behavior | 1 | 2007 | 2630 | 0.010 |
Why?
|
Melanoma | 1 | 2014 | 5462 | 0.010 |
Why?
|
Patient Acceptance of Health Care | 1 | 2007 | 3014 | 0.010 |
Why?
|
Brain Neoplasms | 1 | 2015 | 8829 | 0.010 |
Why?
|
Animals | 2 | 2018 | 168561 | 0.010 |
Why?
|
Mice | 1 | 2018 | 81045 | 0.010 |
Why?
|
Time Factors | 1 | 2011 | 40054 | 0.010 |
Why?
|